P2RY12 and stroke disorder: Aspirin has been the cornerstone of CAD treatment for decades, to which, after ACS, a P2Y12 inhibitor is added to further reduce major adverse cardiac events (MACE, namely cardiovascular death, MI, and stroke) [12].